Show simple item record

dc.contributor.authorRocca, María Florencia
dc.contributor.authorZintgraff, Jonathan
dc.contributor.authorDattero, María Elena
dc.contributor.authorSantos, Leonardo S.
dc.contributor.authorLedesma, Martín M.
dc.contributor.authorVay, Carlos Alberto
dc.contributor.authorPrieto, Mónica A.
dc.contributor.authorBenedetti, Estefanía
dc.contributor.authorAvaro, Martín M.
dc.contributor.authorRusso, Mara L.
dc.contributor.authorNachtigall, Fabiane Manke
dc.contributor.authorBaumeister, Elsa Graciela
dc.date.accessioned2020-10-26T20:55:29Z
dc.date.available2020-10-26T20:55:29Z
dc.date.issued2020-12
dc.identifier10.1016/j.jviromet.2020.113991
dc.identifier.issn01660934
dc.identifier.urihttps://hdl.handle.net/20.500.12728/7083
dc.description.abstractCoronavirus disease 2019, known as COVID-19, is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The early, sensitive and specific detection of SARS-CoV-2 virus is widely recognized as the critical point in responding to the ongoing outbreak. Currently, the diagnosis is based on molecular real time RT-PCR techniques, although their implementation is being threatened due to the extraordinary demand for supplies worldwide. That is why the development of alternative and / or complementary tests becomes so relevant. Here, we exploit the potential of mass spectrometry technology combined with machine learning algorithms, for the detection of COVID-19 positive and negative protein profiles directly from nasopharyngeal swabs samples. According to the preliminary results obtained, accuracy = 67.66 %, sensitivity = 61.76 %, specificity = 71.72 %, and although these parameters still need to be improved to be used as a screening technique, mass spectrometry-based methods coupled with multivariate analysis showed that it is an interesting tool that deserves to be explored as a complementary diagnostic approach due to the low cost and fast performance. However, further steps, such as the analysis of a large number of samples, should be taken in consideration to determine the applicability of the method developed.es_ES
dc.language.isoenes_ES
dc.publisherElsevier B.V.es_ES
dc.subjectCOVID-19es_ES
dc.subjectMachine learninges_ES
dc.subjectMALDI-TOFes_ES
dc.subjectMass spectrometryes_ES
dc.subjectSARS-CoV-2es_ES
dc.titleA combined approach of MALDI-TOF mass spectrometry and multivariate analysis as a potential tool for the detection of SARS-CoV-2 virus in nasopharyngeal swabses_ES
dc.typeArticlees_ES


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record